Cannabisin B

CAS : 144506-17-2

Ref. 3D-UFA50617

Informations sur le produit

• Nom: Cannabisin B
• Synonymes: 2,3-Naphthalenedicarboxamide,1-(3,4-dihydroxyphenyl)-1,2-dihydro-6,7-dihydroxy-N,N'-bis[2-(4-hydroxyphenyl)ethyl]-,(1R,2S)-rel- (9CI), 2,3-Naphthalenedicarboxamide,1-(3,4-dihydroxyphenyl)-1,2-dihydro-6,7-dihydroxy-N,N'-bis[2-(4-hydroxyphenyl)ethyl]-,trans-(?à)-, 2,3-Naphthalenedicarboxamide,1-(3,4-dihydroxyphenyl)-1,2-dihydro-6,7-dihydroxy-N,N'-bis[2-(4-hydroxyphenyl)ethyl]-,trans-

Description

Cannabisin B is an analog of a compound found in cannabis that has shown potential as an anticancer agent. It has been shown to inhibit the growth of cancer cells and tumor formation in Chinese hamsters, as well as induce apoptosis (programmed cell death) in human cancer cells. Cannabisin B works by inhibiting kinases, which are enzymes that regulate protein activity and play a key role in cancer cell growth and survival. This compound is being studied for its medicinal properties and potential use in developing new cancer therapies. It is also being investigated as a potential urine biomarker for detecting cancer early on.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 596.6 g/mol
• Formule: C₃₄H₃₂N₂O₈
• Degré de pureté: Min. 95%